Table 2.
Antibiotic | Susceptible Phenotype | Resistant Phenotype | Agreement | Kappa Coefficiency | p-Value | ||
---|---|---|---|---|---|---|---|
Resistant Genotype | Susceptible Genotype | Resistant Genotype | Susceptible Genotype | ||||
AMX | 0 | 48 | 3 | 2 | 96.20% | 0.73 (95% CI, 0.47–0.99) | 3.29 × 10−8 |
MTZ | 0 | 2 | 30 | 21 | 60.40% | 0.1 (95% CI, 0.02–0.21) | 0.1 |
LVX | 0 | 17 | 29 | 7 | 86.80% | 0.73 (95% CI, 0.47–0.99) | 3.81 × 10−8 |
CLR | 0 | 40 | 11 | 2 | 96.20% | 0.89 (95% CI, 0.62–1.00) | 6.35 × 10−11 |
TET | 0 | 53 | 0 | 0 | - | - | - |